EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,437,000 | +445.2% | 40,560 | +412.6% | 0.02% | +325.0% |
| Q3 2019 | $447,000 | -79.2% | 7,912 | -79.5% | 0.00% | -77.8% |
| Q2 2019 | $2,144,000 | -24.9% | 38,509 | -31.9% | 0.02% | -21.7% |
| Q1 2019 | $2,855,000 | +289.5% | 56,533 | +210.6% | 0.02% | +283.3% |
| Q4 2018 | $733,000 | -77.0% | 18,204 | -60.5% | 0.01% | -62.5% |
| Q3 2018 | $3,192,000 | +0.4% | 46,049 | +9.6% | 0.02% | -5.9% |
| Q2 2018 | $3,179,000 | +80.1% | 42,015 | +25.4% | 0.02% | +70.0% |
| Q1 2018 | $1,765,000 | +183.3% | 33,500 | +186.3% | 0.01% | +233.3% |
| Q4 2017 | $623,000 | -19.7% | 11,700 | -10.0% | 0.00% | -25.0% |
| Q3 2017 | $776,000 | +238.9% | 13,000 | +348.3% | 0.00% | +300.0% |
| Q2 2017 | $229,000 | +308.9% | 2,900 | +314.3% | 0.00% | – |
| Q4 2016 | $56,000 | -82.0% | 700 | -84.2% | 0.00% | -100.0% |
| Q3 2016 | $311,000 | +740.5% | 4,441 | +361.6% | 0.00% | – |
| Q2 2016 | $37,000 | +23.3% | 962 | +140.5% | 0.00% | – |
| Q3 2015 | $30,000 | +275.0% | 400 | +300.0% | 0.00% | – |
| Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |